Srinivas Akkaraju, MD, PhD
Srinivas (Srini) Akkaraju is the Managing General Partner at Samsara, a firm that he founded in 2017. Srini brings over 20 years of experience in biotechnology venture investing at JPMorgan Partners, Panorama, New Leaf, Sofinnova Ventures and Samsara, and in-house business development experience at Genentech. He currently serves on the boards of Chinook Therapeutics, Intercept, Syros and a number of private biotech companies. Srini received his MD and PhD in immunology from Stanford University.